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Skeletal muscle atrophy following denervation may not allow a good functional 
recovery if the muscle is not quickly re-innervated by the regenerating nerve fibers. 
In this regard, both improvement of peripheral nerve regeneration and prevention of 
skeletal muscle atrophy are important to achieve a satisfactory functional recovery 
after nerve injury. Local gene transfer could represent a promising strategyto reach 
this goal. Various genes are candidates in fostering peripheral axon regeneration and 
in preventing muscle atrophy, among these, the vascular endothelial growth factor 
(VEGF).
The main goals of our study were twofold: (i) to accelerate axonal regeneration along 
muscle-vein-combined conduits used to bridge a 1-cm-long rat median nerve gap, and 
(ii) to prevent denervation-related atrophy of Fingers Flexor muscle after complete rat 
median nerve transection.
Results showed that the over-expression of VEGF led to a worse nerve regeneration in 
the muscle-vein-combined guide in comparison to LacZ controls, whereas in the muscle 
it led to a significantly lower progression of atrophy.
Altogether, our results suggest that VEGF direct local injection in denervated skeletal 
muscle significantly attenuates denervation-related atrophy thus representing a promis-
ing strategy for improving the outcome of posttraumatic neuromuscular recovery after 
nerve injury and repair.
